Could muscle loss predict Chemo's painful side effects?
NCT ID NCT06996548
Summary
This study aimed to understand if having low muscle mass (sarcopenia) before treatment makes breast cancer patients more likely to develop nerve damage from a common chemotherapy drug called paclitaxel. Researchers followed 120 early-stage breast cancer patients in Turkey, measuring their muscle from CT scans and tracking nerve symptoms before and after chemo. The goal was to identify patients at higher risk so doctors can better monitor and manage this painful side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ankara Etlik City Hospital
Ankara, Yenimahalle, 06170, Turkey (Türkiye)
-
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Ankara, Yenimahalle, 06200, Turkey (Türkiye)
-
Gazi University
Ankara, Yenimahalle, 06560, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.